HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF

The present invention relates to a heteroaryl derivative compound and a use thereof. A heteroaryl derivative of the present invention exhibits excellent inhibitory activity with respect to EGFR, and thus can be effectively used as a therapeutic agent for EGFR-associated diseases. La présente inventi...

Full description

Saved in:
Bibliographic Details
Main Authors KIM, Kyun Eun, KO, Yi Kyoung, CHOI, Hwan Geun, PARK, Jin Hee, NAM, Su Been, HAN, Ah Reum, LEE, Yeong Deok, IM, Hye Rim, KO, Eun Hwa, HWANG, Dong Keun, KIM, Sung Hwan
Format Patent
LanguageEnglish
French
Korean
Published 30.06.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a heteroaryl derivative compound and a use thereof. A heteroaryl derivative of the present invention exhibits excellent inhibitory activity with respect to EGFR, and thus can be effectively used as a therapeutic agent for EGFR-associated diseases. La présente invention concerne un composé dérivé d'hétéroaryle et son utilisation. Un dérivé d'hétéroaryle de la présente invention présente une excellente activité inhibitrice vis-à-vis de l'EGFR, et peut donc être utilisé efficacement en tant qu'agent thérapeutique pour des maladies associées à EGFR. 본 발명은 헤테로아릴 유도체 화합물 및 이의 용도에 관한 것이다. 본 발명의 헤테로아릴 유도체는 EGFR에 대해 우수한 억제 활성을 나타내므로, 상기 EGFR 관련 질환의 치료제로 유용하게 사용될 수 있다.
Bibliography:Application Number: WO2021KR19439